MX2007008826A - Metodos y composiciones para encapsulacion de celulas. - Google Patents
Metodos y composiciones para encapsulacion de celulas.Info
- Publication number
- MX2007008826A MX2007008826A MX2007008826A MX2007008826A MX2007008826A MX 2007008826 A MX2007008826 A MX 2007008826A MX 2007008826 A MX2007008826 A MX 2007008826A MX 2007008826 A MX2007008826 A MX 2007008826A MX 2007008826 A MX2007008826 A MX 2007008826A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- methods
- cells
- present
- encapsulation
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000005538 encapsulation Methods 0.000 title 1
- 230000024245 cell differentiation Effects 0.000 abstract 2
- 230000003190 augmentative effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 239000002121 nanofiber Substances 0.000 abstract 1
- 210000005155 neural progenitor cell Anatomy 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 230000014511 neuron projection development Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/74—Alginate
Abstract
La presente invencion se refiere a metodos y composiciones para alterar (por ejemplo, aumentar o estimular) la diferenciacion y crecimiento de celulas (por ejemplo, celulas progenitores neurales y neuronas). En particular, la presente invencion se refiere a composiciones que comprenden uno o mas anfifilos peptidicos que se auto-ensamblan (por ejemplo, en solucion o que generan (por ejemplo, se auto-ensamblan como) nanofibras (por ejemplo, que puedan encapsular celulas y promover la diferenciacion celular (por ejemplo desarrollo de neurita))) y a metodos para utilizar las mismas. Las composiciones y metodos de la presente invencion encuentran uso en ambientes de investigacion, clinicos (por ejemplo terapeuticos) y de diagnostico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64566805P | 2005-01-21 | 2005-01-21 | |
PCT/US2006/002354 WO2006079036A2 (en) | 2005-01-21 | 2006-01-23 | Methods and compositions for encapsulation of cells |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007008826A true MX2007008826A (es) | 2007-11-15 |
Family
ID=36692990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007008826A MX2007008826A (es) | 2005-01-21 | 2006-01-23 | Metodos y composiciones para encapsulacion de celulas. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20060247165A1 (es) |
EP (1) | EP1838846A4 (es) |
JP (1) | JP2009500001A (es) |
KR (1) | KR20070100948A (es) |
CN (1) | CN101150954A (es) |
AU (1) | AU2006206194A1 (es) |
CA (1) | CA2590336A1 (es) |
MX (1) | MX2007008826A (es) |
NZ (1) | NZ555294A (es) |
WO (1) | WO2006079036A2 (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002365162A1 (en) * | 2001-11-14 | 2003-07-09 | Northwestern University | Self-assembly and mineralization of peptide-amphiphile nanofibers |
US7371719B2 (en) * | 2002-02-15 | 2008-05-13 | Northwestern University | Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
WO2004018628A2 (en) | 2002-08-21 | 2004-03-04 | Northwestern University | Charged peptide-amphiphile solutions & self-assembled peptide nanofiber networks formed therefrom |
WO2004106359A2 (en) * | 2002-09-23 | 2004-12-09 | Northwestern University | Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals |
US7554021B2 (en) | 2002-11-12 | 2009-06-30 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
WO2004046167A2 (en) * | 2002-11-14 | 2004-06-03 | Northwestern University | Synthesis and self-assembly of abc triblock bola peptide |
KR20050100397A (ko) * | 2003-02-11 | 2005-10-18 | 노오쓰웨스턴 유니버시티 | 나노결정질 표면 코팅을 위한 방법 및 물질, 및 이의상부로의 펩티드 양친매성 나노섬유의 부착 |
MXPA06006388A (es) * | 2003-12-05 | 2006-09-04 | Univ Northwestern | Peptidos anfifilicos de auto-ensamble y metodos relacionados para el suministro del factor de crecimiento. |
MXPA06006387A (es) * | 2003-12-05 | 2006-09-04 | Univ Northwestern | Peptidos anfifilicos ramificados, compuestos epitopes relacionados y estructuras auto-ensambladas de los mismos. |
WO2006096614A2 (en) * | 2005-03-04 | 2006-09-14 | Northwestern University | Angiogenic heparin binding peptide amphiphiles |
CU23526B6 (es) | 2006-10-03 | 2010-05-19 | Ct Ingenieria Genetica Biotech | Método para la restauración morfofuncional de nervios periféricos en la neuropatía diabética |
JP2008184384A (ja) * | 2007-01-26 | 2008-08-14 | Chiba Univ | 軸索再生促進剤およびその候補物質を同定する方法 |
ITRM20070119A1 (it) * | 2007-03-08 | 2008-09-09 | Inbios S R L | Udo del ngf per la preparazione di mendicamenti per la cura della gliosi reattiva |
US8076295B2 (en) * | 2007-04-17 | 2011-12-13 | Nanotope, Inc. | Peptide amphiphiles having improved solubility and methods of using same |
JP2012523463A (ja) * | 2009-04-13 | 2012-10-04 | ノースウエスタン ユニバーシティ | 軟骨再生のための新規なペプチドベースの足場およびその使用方法 |
DE102010001179A1 (de) * | 2010-01-25 | 2011-07-28 | Technische Universität Dresden, 01069 | Verwendung von Hydrogelen auf Basis guluronsäure- und/oder mannuronsäurehaltiger Polysaccharide zur Behandlung von Beschädigungen des Nervensystems, zur Förderung des Nervenwachstums, zur Behandlung von neurodegenerativen Erkrankungen und zur Kultivierung von Neuronen |
GB201011602D0 (en) * | 2010-07-09 | 2010-08-25 | Univ London Pharmacy | Delivery of hydrophilic peptides |
CA2845198A1 (en) * | 2010-08-13 | 2012-02-16 | Georgetown University | Ggf2 and methods of use |
US8546338B2 (en) | 2010-12-08 | 2013-10-01 | Johnson & Johnson Consumer Companies, Inc. | Self-assembling hydrogels based on dicephalic peptide amphiphiles |
US8748569B2 (en) | 2011-04-08 | 2014-06-10 | Northwestern University | Peptide amphiphiles and methods to electrostatically control bioactivity of the ikvav peptide epitope |
KR101472476B1 (ko) * | 2011-11-14 | 2014-12-15 | (주)노바셀테크놀로지 | 콜라겐 합성능이 있는 신규 펩타이드 유도체 및 그의 용도 |
WO2014109417A1 (ko) * | 2013-01-08 | 2014-07-17 | (주)노바셀테크놀로지 | 콜라겐 합성능이 있는 신규 펩타이드 및 그의 용도 |
DK3081637T3 (da) * | 2013-12-11 | 2019-08-12 | Sumitomo Chemical Co | Fremgangsmåde til fremstilling af en ciliær marginalzonelignende struktur |
DE102015000363A1 (de) | 2015-01-20 | 2016-07-21 | Emc Microcollections Gmbh | Neue modular funktionalisierbare Peptid-Hydrogele |
JP7142284B2 (ja) | 2017-06-06 | 2022-09-27 | 株式会社らいむ | 神経伸長促進剤 |
US20210163556A1 (en) * | 2018-04-06 | 2021-06-03 | Northwestern University | Bdnf mimetic peptide amphiphiles |
EP3569261B1 (en) * | 2018-05-14 | 2024-04-03 | Paul Hartmann AG | Functional wound dressing |
CN113777296A (zh) * | 2021-09-16 | 2021-12-10 | 复旦大学附属中山医院 | 一种全量组织免疫荧光方法和应用 |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
US5130123A (en) * | 1981-03-04 | 1992-07-14 | The University Of Melbourne | Dentifrice |
US4930077A (en) * | 1987-04-06 | 1990-05-29 | Fan David P | Information processing expert system for text analysis and predicting public opinion based information available to the public |
GB8812214D0 (en) * | 1988-05-24 | 1988-06-29 | Hoffmann La Roche | Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
DE4026978A1 (de) * | 1990-08-25 | 1992-02-27 | Bayer Ag | Auf traegern angebrachte ein- oder mehrlagige schichtelemente und ihre herstellung |
JP4215273B2 (ja) * | 1991-04-25 | 2009-01-28 | ブラウン ユニヴァーシティ リサーチ ファンデーション | 選択された治療物質放出用の移植可能で生体適合性の免疫遮断性ビークル |
US5955343A (en) * | 1992-12-28 | 1999-09-21 | Massachusetts Institute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
US5670483A (en) * | 1992-12-28 | 1997-09-23 | Massachusetts Insititute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
CA2228118A1 (en) * | 1995-07-28 | 1997-02-13 | Focal, Inc. | Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatments agents |
US5622699A (en) * | 1995-09-11 | 1997-04-22 | La Jolla Cancer Research Foundation | Method of identifying molecules that home to a selected organ in vivo |
US6051272A (en) * | 1996-03-15 | 2000-04-18 | The Board Of Trustees Of The University Of Illinois | Method for synthesizing organoapatites on to surgical metal alloys |
US5733868A (en) * | 1996-04-16 | 1998-03-31 | Depuy Orthopaedics, Inc. | Poly(amino acid) adhesive tissue grafts |
US5853830A (en) * | 1996-06-12 | 1998-12-29 | Hoechst Trespaphan Gmbh | Transparent barrier coatings exhibiting reduced thin film interference |
US6085206A (en) * | 1996-06-20 | 2000-07-04 | Microsoft Corporation | Method and system for verifying accuracy of spelling and grammatical composition of a document |
US5993541A (en) * | 1996-07-31 | 1999-11-30 | Geo Centers Inc | Process for nucleation of ceramics and product thereof |
US6096863A (en) * | 1996-08-23 | 2000-08-01 | Regents Of The University Of Minnesota | Self-assembling amphiphiles for construction of peptide secondary structures |
US6331406B1 (en) * | 1997-03-31 | 2001-12-18 | The John Hopkins University School Of Medicine | Human enbryonic germ cell and methods of use |
US6181909B1 (en) * | 1997-07-22 | 2001-01-30 | Educational Testing Service | System and method for computer-based automatic essay scoring |
US6269368B1 (en) * | 1997-10-17 | 2001-07-31 | Textwise Llc | Information retrieval using dynamic evidence combination |
JP4222726B2 (ja) * | 1997-12-02 | 2009-02-12 | ゼン‐バイオ,インコーポレイテッド | 骨芽細胞の発生および使用 |
GB9801061D0 (en) * | 1998-01-20 | 1998-03-18 | Univ Nottingham | Patterning technique |
SE519827C2 (sv) * | 1998-03-30 | 2003-04-15 | Viranative Ab | Näringsmedium innehållande metionin samt användning av detta |
US7601685B2 (en) * | 1998-08-27 | 2009-10-13 | Eidgenossische Technische Hochschule Zurich | Growth factor modified protein matrices for tissue engineering |
US6207218B1 (en) * | 1998-09-15 | 2001-03-27 | Isotis B.V. | Method for coating medical implants |
US6114038A (en) * | 1998-11-10 | 2000-09-05 | Biocrystal Ltd. | Functionalized nanocrystals and their use in detection systems |
US6473730B1 (en) * | 1999-04-12 | 2002-10-29 | The Trustees Of Columbia University In The City Of New York | Method and system for topical segmentation, segment significance and segment function |
US20090087878A9 (en) * | 1999-05-06 | 2009-04-02 | La Rosa Thomas J | Nucleic acid molecules associated with plants |
US6444723B1 (en) * | 1999-11-10 | 2002-09-03 | The United States Of America As Represented By The Secretary Of Commerce | Crosslinked micellar gel composition |
US20040018969A1 (en) * | 2000-01-31 | 2004-01-29 | Rosen Craig A. | Nucleic acids, proteins, and antibodies |
US6689165B2 (en) * | 2000-03-31 | 2004-02-10 | Board Of Supervisors Of Louisana State University And Agricultural And Mechanical College | Surface modifications for enhanced epithelialization |
AU2001261506A1 (en) * | 2000-05-11 | 2001-11-20 | University Of Southern California | Discourse parsing and summarization |
CA2426692C (en) * | 2000-10-19 | 2011-01-25 | Eidgenossische Technische Hochschule Zurich | Block copolymers for multifunctional self-assembled systems |
CA2436740A1 (en) * | 2001-01-23 | 2002-08-01 | Educational Testing Service | Methods for automated essay analysis |
US7449180B2 (en) * | 2001-02-06 | 2008-11-11 | John Kisiday | Macroscopic scaffold containing amphiphilic peptides encapsulating cells |
ATE419333T1 (de) * | 2001-02-06 | 2009-01-15 | Massachusetts Inst Technology | Peptidgerüstverkapselung von gewebszellen und verwendungen davon |
US7179784B2 (en) * | 2001-07-10 | 2007-02-20 | Massachusetts Institute Of Technology | Surfactant peptide nanostructures, and uses thereof |
AU2002365162A1 (en) * | 2001-11-14 | 2003-07-09 | Northwestern University | Self-assembly and mineralization of peptide-amphiphile nanofibers |
US7371719B2 (en) | 2002-02-15 | 2008-05-13 | Northwestern University | Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
AU2003222167A1 (en) | 2002-04-02 | 2003-10-20 | Northwestern University | Peptide amphiphile solutions and self assembled peptide nanofiber networks |
WO2003090255A2 (en) | 2002-04-18 | 2003-10-30 | Northwestern University | Encapsulation of nanotubes via self-assembled nanostructures |
JP2005185101A (ja) * | 2002-05-30 | 2005-07-14 | National Institute Of Agrobiological Sciences | 植物の全長cDNAおよびその利用 |
WO2004003561A1 (en) | 2002-06-27 | 2004-01-08 | Northwestern University | Peptide rod amphiphiles and self-assembly of same |
WO2004018628A2 (en) | 2002-08-21 | 2004-03-04 | Northwestern University | Charged peptide-amphiphile solutions & self-assembled peptide nanofiber networks formed therefrom |
WO2004106359A2 (en) | 2002-09-23 | 2004-12-09 | Northwestern University | Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals |
US7135027B2 (en) * | 2002-10-04 | 2006-11-14 | Baxter International, Inc. | Devices and methods for mixing and extruding medically useful compositions |
WO2005003292A2 (en) | 2002-11-12 | 2005-01-13 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
US7554021B2 (en) * | 2002-11-12 | 2009-06-30 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
WO2004046167A2 (en) | 2002-11-14 | 2004-06-03 | Northwestern University | Synthesis and self-assembly of abc triblock bola peptide |
KR20050100397A (ko) | 2003-02-11 | 2005-10-18 | 노오쓰웨스턴 유니버시티 | 나노결정질 표면 코팅을 위한 방법 및 물질, 및 이의상부로의 펩티드 양친매성 나노섬유의 부착 |
GB0303362D0 (en) * | 2003-02-13 | 2003-03-19 | Enact Pharma Plc | Tissue regeneration |
MXPA06006388A (es) | 2003-12-05 | 2006-09-04 | Univ Northwestern | Peptidos anfifilicos de auto-ensamble y metodos relacionados para el suministro del factor de crecimiento. |
MXPA06006387A (es) | 2003-12-05 | 2006-09-04 | Univ Northwestern | Peptidos anfifilicos ramificados, compuestos epitopes relacionados y estructuras auto-ensambladas de los mismos. |
US20050214257A1 (en) * | 2003-12-23 | 2005-09-29 | Northwestern University | Compositions and methods for controlling stem cell and tumor cell differentiation, growth, and formation |
EP1740196B1 (en) * | 2004-03-23 | 2015-08-26 | Lifeline Nutraceuticals Corporation | Compositions and method for alleviating inflammation and oxidative stress in a mammal |
EP1838290A2 (en) * | 2005-01-21 | 2007-10-03 | Alza Corporation | Therapeutic peptide formulations for coating microneedles with improved stability containing at least one counterion |
WO2006096614A2 (en) * | 2005-03-04 | 2006-09-14 | Northwestern University | Angiogenic heparin binding peptide amphiphiles |
US8114834B2 (en) * | 2006-11-09 | 2012-02-14 | Northwestern University | Self-assembling peptide amphiphiles |
US8114835B2 (en) * | 2006-11-09 | 2012-02-14 | Northwestern University | Self-assembling peptide amphiphiles for tissue engineering |
US8772228B2 (en) * | 2007-02-14 | 2014-07-08 | Northwestern University | Aligned nanofibers and related methods of use |
US8076295B2 (en) * | 2007-04-17 | 2011-12-13 | Nanotope, Inc. | Peptide amphiphiles having improved solubility and methods of using same |
WO2009026233A2 (en) * | 2007-08-17 | 2009-02-26 | Northwestern University | Self assembling peptide systems and methods |
-
2006
- 2006-01-23 KR KR1020077016821A patent/KR20070100948A/ko not_active Application Discontinuation
- 2006-01-23 WO PCT/US2006/002354 patent/WO2006079036A2/en active Application Filing
- 2006-01-23 MX MX2007008826A patent/MX2007008826A/es not_active Application Discontinuation
- 2006-01-23 EP EP06733823A patent/EP1838846A4/en not_active Withdrawn
- 2006-01-23 JP JP2007552353A patent/JP2009500001A/ja active Pending
- 2006-01-23 US US11/337,316 patent/US20060247165A1/en not_active Abandoned
- 2006-01-23 CN CNA2006800026166A patent/CN101150954A/zh active Pending
- 2006-01-23 NZ NZ555294A patent/NZ555294A/en not_active IP Right Cessation
- 2006-01-23 CA CA002590336A patent/CA2590336A1/en not_active Abandoned
- 2006-01-23 AU AU2006206194A patent/AU2006206194A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20060247165A1 (en) | 2006-11-02 |
WO2006079036A2 (en) | 2006-07-27 |
EP1838846A2 (en) | 2007-10-03 |
EP1838846A4 (en) | 2008-12-10 |
CN101150954A (zh) | 2008-03-26 |
WO2006079036A3 (en) | 2007-11-22 |
KR20070100948A (ko) | 2007-10-15 |
JP2009500001A (ja) | 2009-01-08 |
CA2590336A1 (en) | 2006-07-27 |
AU2006206194A1 (en) | 2006-07-27 |
NZ555294A (en) | 2010-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007008826A (es) | Metodos y composiciones para encapsulacion de celulas. | |
AU2017368136B2 (en) | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | |
MX2012001194A (es) | Peptidos tau antigenicos y usos de los mismos. | |
HRP20050585A2 (en) | Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof | |
WO2009135855A3 (en) | Encapsulation of biologically active agents | |
JP2016516023A5 (es) | ||
DE602006017071D1 (de) | Zusammensetzungen und verfahren zur behandlung von herzkrankheiten | |
EA201171279A1 (ru) | Производство инкапсулированных наночастиц с высокой объемной долей | |
HK1145070A1 (en) | Therapeutic use of a growth factor, metrnl | |
WO2009135190A3 (en) | Therapeutic calcium phosphate particles and methods of making and using same | |
WO2009135853A3 (en) | Encapsulation of biologically active agents | |
WO2010085039A3 (ko) | 노긴―유래 펩타이드 및 그의 용도 | |
WO2007024441A3 (en) | Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof | |
MX2011007583A (es) | Nuevas formulaciones estables de proteina de fusion recombinante de albumina humana-factor humano de estimulacion de colonias de granulocitos. | |
SG10201407403UA (en) | Treatments For Gastrointestinal Disorders | |
GB201001602D0 (en) | Oligopeptidic compounds and uses therof | |
UA100127C2 (ru) | Пептид cdh3 и лекарственное средство, содержащее его | |
EA200702523A1 (ru) | Применение эритропоэтина в низкой дозировке для стимуляции эндотелиальных клеток-предшественников, а также для регенерации органов и замедления прогрессирования повреждений конечных органов | |
EA201170659A1 (ru) | Антитела к рецептору ii tgf-вета | |
MX344815B (es) | Metodo para purificar el factor estimulante de colonias de granulocitos humano a partir de e. coli recombinante. | |
DE60138558D1 (de) | Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung | |
MX2011007462A (es) | Composiciones que contienen acido hialuronico para el tratamiento de heridas, cicatrices, formacion de dahesiones postquirurgicas. | |
CL2008001211A1 (es) | Compuestos derivados de benzotriazolilfenol sililado; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento contra condiciones no deseadas de la piel tales como queratosis actinica, urticaria solar y eritema solar. | |
MX2018000699A (es) | Peptidos promotores del crecimiento y usos de los mismos. | |
WO2010057275A8 (en) | Cyclic peptides and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |